US10894052B2

Heterocyclic inhibitors of ATR kinase

University of Texas System

Abstract

The present disclosure relates to heterocyclic compounds and methods which inhibit ATR kinase to treat or prevent cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Maria Emilia Di Francesco
Priority date: March 16, 2018
Filing date: March 18, 2019
Grant date: January 19, 2021
Publication date: January 19, 2021
Language: en
PDF source: https://patentimages.storage.googleapis.com/5c/b1/34/a93315896b6891/US10894052.pdf
Metadata fetched: August 29, 2026 00:28